CN115040614A - 一种用于治疗类风湿关节炎的侗医药组方 - Google Patents
一种用于治疗类风湿关节炎的侗医药组方 Download PDFInfo
- Publication number
- CN115040614A CN115040614A CN202210532571.4A CN202210532571A CN115040614A CN 115040614 A CN115040614 A CN 115040614A CN 202210532571 A CN202210532571 A CN 202210532571A CN 115040614 A CN115040614 A CN 115040614A
- Authority
- CN
- China
- Prior art keywords
- dong
- rheumatoid arthritis
- medicinal
- treating rheumatoid
- root
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010039073 rheumatoid arthritis Diseases 0.000 title claims abstract description 43
- 239000000203 mixture Substances 0.000 title claims abstract description 16
- 239000000463 material Substances 0.000 claims abstract description 13
- 208000006820 Arthralgia Diseases 0.000 claims abstract description 7
- 244000077995 Coix lacryma jobi Species 0.000 claims abstract description 6
- 241000208682 Liquidambar Species 0.000 claims abstract description 6
- 235000006552 Liquidambar styraciflua Nutrition 0.000 claims abstract description 6
- 244000153955 Reynoutria sachalinensis Species 0.000 claims abstract description 6
- 235000003202 Reynoutria sachalinensis Nutrition 0.000 claims abstract description 6
- 241000059156 Toddalia Species 0.000 claims abstract description 6
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 6
- 241000157373 Uncaria rhynchophylla Species 0.000 claims abstract description 5
- 239000002994 raw material Substances 0.000 claims abstract description 4
- 238000005406 washing Methods 0.000 claims abstract description 3
- 239000003814 drug Substances 0.000 claims description 34
- 239000007788 liquid Substances 0.000 claims description 15
- 238000000034 method Methods 0.000 claims description 13
- 229940079593 drug Drugs 0.000 claims description 10
- 238000002360 preparation method Methods 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- 238000002791 soaking Methods 0.000 claims description 7
- 238000001035 drying Methods 0.000 claims description 5
- 239000008213 purified water Substances 0.000 claims description 5
- 238000004140 cleaning Methods 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 238000003672 processing method Methods 0.000 claims description 2
- 238000000605 extraction Methods 0.000 claims 1
- 210000000582 semen Anatomy 0.000 claims 1
- 238000003809 water extraction Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 9
- 208000024891 symptom Diseases 0.000 abstract description 5
- 206010067484 Adverse reaction Diseases 0.000 abstract description 4
- 230000006838 adverse reaction Effects 0.000 abstract description 4
- 239000012567 medical material Substances 0.000 abstract description 4
- 208000002193 Pain Diseases 0.000 abstract description 3
- 206010049119 Emotional distress Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 9
- 201000010099 disease Diseases 0.000 description 7
- 238000001467 acupuncture Methods 0.000 description 4
- 229940126673 western medicines Drugs 0.000 description 4
- 206010003694 Atrophy Diseases 0.000 description 2
- 230000037444 atrophy Effects 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 2
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 210000002435 tendon Anatomy 0.000 description 2
- 229940126680 traditional chinese medicines Drugs 0.000 description 2
- LJRDOKAZOAKLDU-UDXJMMFXSA-N (2s,3s,4r,5r,6r)-5-amino-2-(aminomethyl)-6-[(2r,3s,4r,5s)-5-[(1r,2r,3s,5r,6s)-3,5-diamino-2-[(2s,3r,4r,5s,6r)-3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-hydroxycyclohexyl]oxy-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]oxyoxane-3,4-diol;sulfuric ac Chemical compound OS(O)(=O)=O.N[C@@H]1[C@@H](O)[C@H](O)[C@H](CN)O[C@@H]1O[C@H]1[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](N)C[C@@H](N)[C@@H]2O)O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)N)O[C@@H]1CO LJRDOKAZOAKLDU-UDXJMMFXSA-N 0.000 description 1
- WHTVZRBIWZFKQO-AWEZNQCLSA-N (S)-chloroquine Chemical compound ClC1=CC=C2C(N[C@@H](C)CCCN(CC)CC)=CC=NC2=C1 WHTVZRBIWZFKQO-AWEZNQCLSA-N 0.000 description 1
- VOBDXTSTTMAKHK-VHDCPBDGSA-N 3870-07-3 Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H]3OC(C)(C)O[C@@]3(C(=O)COC(=O)C)[C@@]1(C)C[C@@H]2O VOBDXTSTTMAKHK-VHDCPBDGSA-N 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 1
- 108010008165 Etanercept Proteins 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 1
- HLFSDGLLUJUHTE-SNVBAGLBSA-N Levamisole Chemical compound C1([C@H]2CN3CCSC3=N2)=CC=CC=C1 HLFSDGLLUJUHTE-SNVBAGLBSA-N 0.000 description 1
- 241001571764 Lysimachia christinae Species 0.000 description 1
- 208000018359 Systemic autoimmune disease Diseases 0.000 description 1
- 241001197778 Tripterygium hypoglaucum Species 0.000 description 1
- 241000830536 Tripterygium wilfordii Species 0.000 description 1
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 1
- 241000157352 Uncaria Species 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 229960002964 adalimumab Drugs 0.000 description 1
- 230000001780 adrenocortical effect Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 229940111131 antiinflammatory and antirheumatic product propionic acid derivative Drugs 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 229960005207 auranofin Drugs 0.000 description 1
- AUJRCFUBUPVWSZ-XTZHGVARSA-M auranofin Chemical compound CCP(CC)(CC)=[Au]S[C@@H]1O[C@H](COC(C)=O)[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@H]1OC(C)=O AUJRCFUBUPVWSZ-XTZHGVARSA-M 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 229960003677 chloroquine Drugs 0.000 description 1
- WHTVZRBIWZFKQO-UHFFFAOYSA-N chloroquine Natural products ClC1=CC=C2C(NC(C)CCCN(CC)CC)=CC=NC2=C1 WHTVZRBIWZFKQO-UHFFFAOYSA-N 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- MOVRKLZUVNCBIP-RFZYENFJSA-N cortancyl Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(=O)COC(=O)C)(O)[C@@]1(C)CC2=O MOVRKLZUVNCBIP-RFZYENFJSA-N 0.000 description 1
- 229960004397 cyclophosphamide Drugs 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- VXIHRIQNJCRFQX-UHFFFAOYSA-K disodium aurothiomalate Chemical compound [Na+].[Na+].[O-]C(=O)CC(S[Au])C([O-])=O VXIHRIQNJCRFQX-UHFFFAOYSA-K 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 229960000403 etanercept Drugs 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- ZWJINEZUASEZBH-UHFFFAOYSA-N fenamic acid Chemical compound OC(=O)C1=CC=CC=C1NC1=CC=CC=C1 ZWJINEZUASEZBH-UHFFFAOYSA-N 0.000 description 1
- 210000002683 foot Anatomy 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 229940111120 gold preparations Drugs 0.000 description 1
- 210000004247 hand Anatomy 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 229940125721 immunosuppressive agent Drugs 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- 229960000905 indomethacin Drugs 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 229960000598 infliximab Drugs 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 229960001614 levamisole Drugs 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 229960000485 methotrexate Drugs 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 229960001639 penicillamine Drugs 0.000 description 1
- 150000005599 propionic acid derivatives Chemical class 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 210000002027 skeletal muscle Anatomy 0.000 description 1
- 229960001315 sodium aurothiomalate Drugs 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 235000015398 thunder god vine Nutrition 0.000 description 1
- 102000003390 tumor necrosis factor Human genes 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 210000000707 wrist Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/45—Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/59—Menispermaceae (Moonseed family), e.g. hyperbaena or coralbead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
- A61K36/8994—Coix (Job's tears)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Rheumatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Dermatology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种用于治疗类风湿关节炎的侗医药组方，以质量克(g)计由如下原料组分制成：药材钩藤根30g、透骨香20g、薏苡仁根20g、路路通20g、软筋藤20g、飞龙掌血20g、虎杖20g。本发明通过将主治类风湿关节炎的一组侗族药材相结合，利用药材相互间的协同或抵抗作用，提高了治疗效果，减少了不良反应以取得标本兼治的作用效果。该侗医药组方以侗医药材煎煮制得汤剂外用，通过侗医药熏洗患者关节疼痛部位，从根本上缓解了患者类风湿关节炎临床症状，减轻了类风湿关节炎病人的身体痛苦和精神折磨。
Description
技术领域
本发明涉及类风湿性关节炎治疗技术领域，尤其涉及一种用于治疗类风湿关节炎的侗医药组方。
技术背景
类风湿性关节炎(Rheumatism Arthritis，RA)是一种以关节滑膜炎为特征的慢性、全身性自身免疫性疾病，以慢性、对称性、多滑膜关节炎和关节外病变为主要临床表现，好发于手、腕、足等小关节，其发病原因可能与机体内分泌、营养、职业、心理和社会环境差异、细菌和病毒感染及遗传因素等有关。早期出现机体关节红肿热痛和功能障碍，晚期关节可出现不同程度的僵硬畸形，并伴有骨和骨骼肌的萎缩，极易致残。类风湿性关节炎至今尚无特效疗法，目前西药药物治疗仍停留于对炎症及后遗症的治疗上，难以控制病情进展或具有严重的不良反应。
常用药物主要包括非甾体类抗炎药(NSAIDS)如水杨酸制剂、吲哚美辛、丙酸衍生物、灭酸类药物等；金制剂如硫代苹果酸金钠、金诺芬等；免疫抑制剂如环磷酰胺、氨甲喋呤等；肾上腺皮质激素如醋酸氢代泼尼松、去炎舒松特丁乙酸酯等；生物制剂如肿瘤坏死因子药物有英利昔单抗、依那西普和阿达木单抗等；青霉胺、氯喹、左旋咪唑和中药雷公藤、昆明山海棠等。据相关报道，我国类风湿性关节炎的患病率大约为0.32％～0.36％，以20～50岁青壮年居多，且存在明显的性别差异，女性发病率约为男性的2～3倍。按此发病率推算，我国患类风湿性关节炎的人数已超过450万。
结合相关流行病学中患者地域分布情况和消费者调查报告的结果，估计有76万人是大城市RA患者，81万是中小城市RA患者，233 万人是农村RA患者。根据抽样调查大城市的被访患者人均购买相关药物的金额3553元，中小城市的人均购买相关药物1502元，农村的人均购买金额为847元，再加上医疗保险制度越趋完善，医疗报销范围增大，报销比例增高一系列的政策支持。国内类风湿性关节炎用药市场的理论分析市场规模已超过85亿元。类风湿性关节炎属于中医“痹症”范畴，外因是以风、寒、湿邪为主，兼有饮食、情志等因素，内因是人体肝肾亏虚而致寒湿、瘀血集于经络、肌肉，导致经络阻滞，肢体萎缩变形等。黔东南苗族侗族自治州位于贵州省东南地区，夏季多风多湿，冬季多风多寒，导致风湿病的发病率极高，在与疾病斗争的过程中，发现了许多对类风湿病治疗有效的药物及组合。
目前，现有用于治疗类风湿性关节炎的方法主要有西药、中药、少数民族医药、针灸等，但是西药一般治标不治本，很容易复发且有一定的副作用。针灸的治疗周期长，而现有的中药治疗效果又很不明显，给人们的日常生活造成很大困扰。
发明内容
1.要解决的技术问题
本发明的目的是为了解决现有技术中治疗类风湿性关节炎的方法主要有西药、中药、针灸，但是西药一般治标不治本，很容易复发，针灸治疗周期长等问题。为解决这一系列问题，进而提出了一种少数民族地区侗族民间医常常用于治疗类风湿关节炎的独特的、经验的、有效的侗医药组方及使用方法。
2.技术方案
为了实现上述目的，本发明采用了如下技术方案：
一种用于治疗类风湿关节炎的侗医药组方，以质量克(g)计由如下原料组分制成：药材钩藤根30g、透骨香20g、薏苡仁根20g、路路通20g、软筋藤20g、飞龙掌血20g、虎杖20g。
本发明中还提出了一种用于治疗类风湿关节炎的侗医药组方的制备和使用方法，应用于制备预防或治疗类风湿关节炎疾病中。包括以下步骤：
步骤1：选用新鲜的侗族医用药材钩藤根、透骨香、薏苡仁根、路路通、软筋藤、飞龙掌血、虎杖，经清洗、干燥、切片等前处理后，以一定炮制方法炮制后制得药材饮片备用；
步骤2：取步骤1所得侗医药材饮片，按照一定料液比向侗医药材饮片中加入10倍量的纯化水，浸泡1小时后，60℃下提取20分钟, 过滤收集水提取液；
步骤3：将煎好的上述侗医治疗类风湿关节炎药材汤剂趁热倒入已有热水的浴盆内，先用侗医药液热气熏蒸患处约5～10分钟，再用毛巾浸汁热敷患者疼痛关节局部，待药液温度降到40℃左右时，嘱患者将疼痛关节或全身置入浴具内，药液泡洗患处约15分钟。
步骤4：无菌纱布擦干患者身体部位。
优选地，所述步骤2中侗药材饮片与纯化水的料液比为1:10的比例。
优选地，所述步骤2中干燥温度60℃。
优选地，应用于制备预防或治疗类风湿关节炎药物中。
3.有益效果
相比于现有技术，本发明的优点在于：
本发明中，通过将侗族地区民间安全的、有效的主治类风湿关节炎的侗族医药相结合，利用相互间的协同或抵抗作用，提高了治疗效果，减少了不良反应，标本兼治。即侗医药方汤剂外用方法，从根本上治愈了类风湿关节炎患者，给患者减轻了病痛折磨，使其能够开展正常的日常生活。
具体实施方式
下面将对本发明实施例中的技术方案进行清楚、完整地描述。
实施例：
一种用于治疗类风湿关节炎的侗医药组方，以质量克(g)计由如下原料组分制成：钩藤根30g、透骨香20g、薏苡仁根20g、路路通20g、软筋藤20g、飞龙掌血20g、虎杖20g。
本发明中，一种用于治疗类风湿关节炎的侗医药组方的制备和使用方法，包括以下步骤：
步骤1:取新鲜药材钩藤根、透骨香、薏苡仁根、路路通、软筋藤、飞龙掌血和虎杖。分别清洗、干燥、切片等炮制加工技术，混合得侗医药材饮片。
步骤2：取步骤1所得侗药材饮片按照一定料液比向侗医药材饮片中加入10倍量的纯化水，浸泡1小时后，60℃下提取20分钟,过滤收集水提取液。
步骤3：将煎好的上述侗医治疗类风湿关节炎药材汤剂趁热倒入已有热水的浴盆内，先用药热气熏蒸患者暴露的全身或局部关节约 5～10分钟后，再用毛巾浸汁热敷局部。待药液温度降到40℃左右时，嘱患者将疼痛关节或全身放入浴具内，再用药液泡洗患处约15分钟。
步骤4：无菌纱布擦干患者身体部位。
本发明中，一种用于治疗类风湿关节炎的侗医药组方的组成，制备和使用方法，应用于制备预防或治疗类风湿关节炎疾病中。通过将主治类风湿的侗医药相结合，利用药材相互间的协同或抵抗作用，提高了治疗效果，减少了不良反应，以达到标本兼治的效果。即侗医药方汤剂外用方法，从根本上治愈了患者的类风湿关节炎疾病，同时，为患者减轻了病痛折磨，使其能够开展正常的日常生活。
以上所述，仅为本发明较佳的具体实施方式，但本发明的保护范围并不局限于此，任何熟悉本技术领域的技术人员在本发明揭露的技术范围内，根据本发明的技术方案及其发明构思加以等同替换或改变，都应涵盖在本发明的保护范围之内。
Claims (5)
1.一种用于治疗类风湿关节炎的侗医药组方，其特征在于，以质量克(g)计由如下原料组分制成：药材钩藤根30g、透骨香20g、薏苡仁根20g、路路通20g、软筋藤20g、飞龙掌血20g、虎杖20g。
2.根据权利要求1所述的一种用于治疗类风湿关节炎的侗医药组方的制备方法，其特征在于，包括以下步骤：
步骤1：取新鲜的侗族药材钩藤根、透骨香、薏苡仁根、路路通、软筋藤、飞龙掌血、虎杖进行药材清洗，干燥、切片等前处理后，经一定炮制方法炮制后制得药材饮片备用；
步骤2:取步骤1所得侗族药材饮片按照一定料液比装入药材提取装置中，加10倍量纯化水，浸泡1小时后进行煎煮，60℃下提取20分钟，过滤，收集侗医药材水提取溶液；
步骤3：将煎好的上述侗医用于治疗类风湿关节炎药材汤剂趁热倒入已盛有热水的浴盆内，先用浴盆内的药液热气熏蒸患者暴露的疼痛关节部位约5～10分钟，再用毛巾浸汁热敷局部，待药液温度降到40℃左右时，嘱患者将疼痛关节或全身置于浴具内，药液泡洗患处约15分钟。
步骤4：无菌纱布擦干患者身体部位。
3.根据权利要求1所述的一种用于治疗类风湿关节炎的侗医药组方的制备方法，其特征在于，所述步骤2中侗医药材饮片与纯化水的料液比为1:10的比例。
4.根据权利要求2所述的一种用于治疗类风湿关节炎的侗医药组方的制备方法，其特征在于，所述步骤2中干燥温度60℃。
5.根据权利要求1所述的一种用于治疗类风湿关节炎的侗医药组方的组成方法和权利要求2所述侗医药组方的使用方法，其特征在于，应用于制备预防或治疗类风湿关节炎药物中。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210532571.4A CN115040614A (zh) | 2022-05-10 | 2022-05-10 | 一种用于治疗类风湿关节炎的侗医药组方 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210532571.4A CN115040614A (zh) | 2022-05-10 | 2022-05-10 | 一种用于治疗类风湿关节炎的侗医药组方 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN115040614A true CN115040614A (zh) | 2022-09-13 |
Family
ID=83157975
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202210532571.4A Pending CN115040614A (zh) | 2022-05-10 | 2022-05-10 | 一种用于治疗类风湿关节炎的侗医药组方 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN115040614A (zh) |
-
2022
- 2022-05-10 CN CN202210532571.4A patent/CN115040614A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN108969642B (zh) | 一种治疗慢性前列腺炎的中药复方外用制剂及其制备工艺 | |
| CN1322885C (zh) | 多用途治疗伤湿痹痛的膏贴药物组合物 | |
| CN115770279B (zh) | 用于治疗慢性下肢静脉疾病的中药组合物及其汤剂和制剂 | |
| CN104887747A (zh) | 一种治疗脑血栓的中药组合物及其制备方法 | |
| CN103463373B (zh) | 一种治疗肾积水的苗药 | |
| CN109464517A (zh) | 清热解毒儿科外用按摩软膏配方、制备软膏的方法及应用 | |
| CN104706953A (zh) | 一种治疗慢性子宫颈炎的中药制剂 | |
| CN115040614A (zh) | 一种用于治疗类风湿关节炎的侗医药组方 | |
| CN1315516C (zh) | 一种治疗风湿病的药物 | |
| CN107617081B (zh) | 一种治疗脱发的中药组合物及其制剂与制备方法 | |
| CN105233078A (zh) | 一种用于治疗病毒性肝炎的中药组合物 | |
| CN104857394A (zh) | 一种治疗痛风的中药组合制剂及其制备方法 | |
| CN104971271A (zh) | 一种治疗瘀湿化热型前列腺增生的药物及制备方法 | |
| CN105327285A (zh) | 一种用于治疗胃窦炎的药物 | |
| CN104840865A (zh) | 一种治疗痛风性关节炎的中药制剂 | |
| CN1330323C (zh) | 一种用于治疗痛风疾病的外用洗浴液及其制备方法 | |
| CN104056127A (zh) | 一种治疗慢性肾炎的中药 | |
| CN103301373A (zh) | 一种治疗产后会阴粘膜病变的药物组合物 | |
| CN115429869B (zh) | 一种治疗寒湿痹阻型腰痛的中药物组合物及其制备方法 | |
| CN103316270B (zh) | 一种治疗产后会阴粘膜病变药物的散剂制备方法 | |
| CN110251564B (zh) | 一种治疗痛风关节炎的外用药及其制备方法 | |
| CN110354243B (zh) | 一种治疗肛周脓肿术后初期的中药组合物、制备方法及其应用 | |
| CN102670858B (zh) | 一种治疗炎性外痔的洗剂 | |
| CN105943700A (zh) | 一种补肾通痹的中药组合物及其制备方法和应用 | |
| CN105169342A (zh) | 一种治疗湿疹的中药组合物及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20220913 |